Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Venous Thromboembolism in Children, Adolescents and Young Adults: Findings from the Riete Registry

Omri Cohen, Assaf Arie Barg, Ulrike Nowak-Göttl, Reina Valle, Lucia Mazzolai, Gregorio Tiberio, Sebastian Schellong, Andris Skride, Mª del Valle Morales, Manuel Monreal, Gili Kenet

Blood (2022) 140 (Supplement 1): 5692–5693.

https://doi.org/10.1182/blood-2022-159499

Published: 2022

Journal Articles

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Fakiha Siddiqui, Priya Ray, Amir Darki, Debra Hoppensteadt, Emily Krupa, Alfonso J. Tafur, Grigoris Gerotziafas, Jawed Fareed, Manuel Monreal

Blood (2022) 140 (Supplement 1): 11214–11215.

https://doi.org/10.1182/blood-2022-165790

Published: 2022

Journal Articles

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Fakiha Siddiqui, Amir Darki, Debra Hoppensteadt, Alfonso J. Tafur, Grigoris Gerotziafas, Jawed Fareed, Manuel Monreal

Blood (2022) 140 (Supplement 1): 11211–11213.

https://doi.org/10.1182/blood-2022-165767

Published: 2022

Journal Articles

Endogenous Thrombin Generation Potential in Patients with Pulmonary Embolism and Its Relevance to Thrombo-Inflammatory Biomarkers

Nusrat Jabeen, Fakiha Siddiqui, Amir Darki, Debra Hoppensteadt, Bulent Kantarcioglu, Mushtaq Hussain, Manuel Monreal, Jawed Fareed

Blood (2022) 140 (Supplement 1): 11220–11221.

https://doi.org/10.1182/blood-2022-165810

Published: 2022

Journal Articles

Sex Differences in Risk Factors, Clinical Presentation, Treatment and Outcomes of Patients Presenting with Acute Pulmonary Embolism

Rachel P Rosovsky, MDMPH, Islam Y Elgendy, MD, Suzanne C Cannegieter, MD PhD, Menno V Huisman, MD PhD, David Jimenez, MD PhD, Jorge del Toro, MD, Vladimir Rosa, MD PhD, Carmen Fernández-Capitán, MD PhD, Alessandra Bura-Riviere, MD PhD, Manuel Monreal, MD PhD

Blood (2019) 134 (Supplement_1): 2429.

https://doi.org/10.1182/blood-2019-131090

Published: 2019

Journal Articles

Higher Rates of Death and Major Bleeding Highlight the Inequities That Exist in the Care of People with Venous Thromboembolism Who Experience Social Exclusion: Findings from a Prospective Registry of 79735 Patients (RIETE)

Karl Ewins, Fionnuala Ni Ainle, PhD, Cliona Ni Cheallaigh, MB BCH MRCPI PhD, Eoghan Dunlea, MB BCh MRCPI, Sarah Kelliher, MBBS, Egidio Imbalzano, MD, Cristiano Bortoluzzi, MD, Inés Jou, MD, Joaquín Alfonso-Megido, María del Carmen Díaz-Pedroche, Manuel Monreal, MD PhD

Blood (2019) 134 (Supplement_1): 4677.

https://doi.org/10.1182/blood-2019-130745

Published: 2019

Journal Articles

Risk Factors for Venous Ulcer Following ACUTE Venous Thromboembolism: Results from the Riete Registry

Jean-Philippe Galanaud, MD PhD, Laurent Bertoletti, MD PhD, Paolo Prandoni, MD PhD, Pedro Gallego, MD PhD, Daniela Mastroiacovo, MD, Lucia Mazzolai, MD PhD, Angel Samperiz, MD PhD, Yacine Rabah, MD, Nuria Ruiz-Gimenez, MD PhD, Marija Zdraveska, MD, Susan R Kahn, MD MSc, Manuel Monreal, MD PhD

Blood (2015) 126 (23): 3548.

https://doi.org/10.1182/blood.V126.23.3548.3548

Published: 2015

Journal Articles

Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis

Chatree Chai-Adisaksopha, MD, Alfonso Iorio, MD PhD, Mark A. Crowther, MD MSc, FRCPC, Javier de Miguel, MD, Estuardo Salgado, MD, Marija Zdraveska, MD, Manuel Monreal, MD PhD

Blood (2015) 126 (23): 430.

https://doi.org/10.1182/blood.V126.23.430.430

Published: 2015

Journal Articles

International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients

Blood (2012) 120 (21): 1161.

https://doi.org/10.1182/blood.V120.21.1161.1161

Published: 2012

Journal Articles

International Clinical Practice Guidelines for the Treatment and Prophylaxis of Thrombosis Associated with Central Venous Catheters in Patients with Cancer

Blood (2012) 120 (21): 4357.

https://doi.org/10.1182/blood.V120.21.4357.4357

Published: 2012

Journal Articles

Silent Pulmonary Embolism in Patients with Lower Limb Deep Vein Thrombosis

Inna Tsoran-Rosenthal, MD, Gleb Sakharov, Benjamin Brenner, MD, Karine Rivron-Guillot, MD, Adriana VisonÁ, MD, David JimÉnez, MD, PhD, Manuel Monreal, MD, PhD

Blood (2011) 118 (21): 2306.

https://doi.org/10.1182/blood.V118.21.2306.2306

Published: 2011

Journal Articles

Venous Thromboembolism Risk in Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Sub-Analysis of the EXCLAIM Study

Alexander GG Turpie, MD, Russell D Hull, MBBS, Sebastian M Schellong, MD, Victor F Tapson, MD, Manuel Monreal, MD, Meyer Michel Samama, MD, PharmD, Roger D Yusen, MD, MPH

Blood (2008) 112 (11): 433.

https://doi.org/10.1182/blood.V112.11.433.433

Published: 2008

Journal Articles

The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely Ill Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study

Roger D Yusen, Russell D Hull, Sebastian M Schellong, Victor F Tapson, Manuel Monreal, Michel Meyer Samama, Min Chen, Alexander GG Turpie

Blood (2008) 112 (11): 438.

https://doi.org/10.1182/blood.V112.11.438.438

Published: 2008

Journal Articles

The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM.

Frederick A Anderson, Jr., PhD, Russell D Hull, MBBS, Sebastian M Schellong, MD, Bruno Deslandes, Victor F Tapson, MD, Meyer Michel Samama, MD, PharmD, Alexander GG Turpie, MD, Roger D Yusen, MD, MPH, Herve Decousus, MD, Alexander T Cohen, MBBS, MSc, MD, FRACP, Manuel Monreal, MD

Blood (2008) 112 (11): 1981.

https://doi.org/10.1182/blood.V112.11.1981.1981

Published: 2008

Journal Articles

The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study.

Roger D. Yusen, Russell D. Hull, Sebastian M. Schellong, Victor F. Tapson, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie

Blood (2007) 110 (11): 1862.

https://doi.org/10.1182/blood.V110.11.1862.1862

Published: 2007

Journal Articles

Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study.

Victor F. Tapson, Russell D. Hull, Sebastian M. Schellong, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie, Roger D. Yusen

Blood (2007) 110 (11): 1863.

https://doi.org/10.1182/blood.V110.11.1863.1863

Published: 2007

Journal Articles

Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint.

Sebastian M. Schellong, Russell D. Hull, Victor F. Tapson, Manuel Monreal, Meyer-Michel Samama, Alexander G.G. Turpie, Roger D. Yusen

Blood (2007) 110 (11): 1870.

https://doi.org/10.1182/blood.V110.11.1870.1870

Published: 2007

Journal Articles

Influence of Perceived Risk Factors for Bleeding on Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients: Findings from IMPROVE.

Manuel Monreal, MD, Rainer B. Zotz, MD, Hervé Decousus, MD, Beng H. Chong, MD, PhD, Geno Merli, MD, Ricardo Pavanello, MD, Mario Pini, MD, Alexander G.G. Turpie, MD, Wei Huang, Frederick A. Anderson, Jr., PhD, for the IMPROVE Investigators

Blood (2005) 106 (11): 917.

https://doi.org/10.1182/blood.V106.11.917.917

Published: 2005

Journal Articles

Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).

Hervé Decousus, MD, Rainer B. Zotz, MD, Victor F. Tapson, MD, Beng H. Chong, MD, PhD, James B. Froehlich, MD, Ricardo Pavanello, MD, Alex C. Spyropoulos, MD, Manuel Monreal, MD, Gordon FitzGerald, Frederick A. Anderson, Jr., PhD, for the IMPROVE Investigators

Blood (2005) 106 (11): 264.

https://doi.org/10.1182/blood.V106.11.264.264

Published: 2005

Journal Articles

Clinical Outcome of Patients with Venous Thromboembolism and Recent Major Bleeding: Findings from a Prospective Registry (RIETE).

Manuel Monreal, José Nieto, Ana de Tuesta, Pablo Marchena, Gregorio Tiberio, José Todoli, Angel Samperiz, the RIETE Investigators

Blood (2004) 104 (11): 708.

https://doi.org/10.1182/blood.V104.11.708.708

Published: 2004

NARROW

Venous Thromboembolism in Children, Adolescents and Young Adults: Findings from the Riete Registry

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Endogenous Thrombin Generation Potential in Patients with Pulmonary Embolism and Its Relevance to Thrombo-Inflammatory Biomarkers

Sex Differences in Risk Factors, Clinical Presentation, Treatment and Outcomes of Patients Presenting with Acute Pulmonary Embolism

Higher Rates of Death and Major Bleeding Highlight the Inequities That Exist in the Care of People with Venous Thromboembolism Who Experience Social Exclusion: Findings from a Prospective Registry of 79735 Patients (RIETE)

Risk Factors for Venous Ulcer Following ACUTE Venous Thromboembolism: Results from the Riete Registry

Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis

International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients

International Clinical Practice Guidelines for the Treatment and Prophylaxis of Thrombosis Associated with Central Venous Catheters in Patients with Cancer

Silent Pulmonary Embolism in Patients with Lower Limb Deep Vein Thrombosis

Venous Thromboembolism Risk in Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Sub-Analysis of the EXCLAIM Study

The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely Ill Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study

The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM.

The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study.

Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study.

Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint.

Influence of Perceived Risk Factors for Bleeding on Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients: Findings from IMPROVE.

Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).

Clinical Outcome of Patients with Venous Thromboembolism and Recent Major Bleeding: Findings from a Prospective Registry (RIETE).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only